{"transactions":[{"id":2088183,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-12-13T18:06:08.000Z","date":"2022-12-09","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest in a series of 16 successive equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":1.8,"expiration_date":"2032-12-08","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-061031","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122061031/doc4.xml","form_type":"4"}},{"id":2167758,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-09-02T17:12:05.000Z","date":"2022-09-01","kind":"purchase","acquired":true,"shares":7500,"price":3.393,"value":25447.5,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction was $3.393. The shares were purchased at a range of prices between $3.36 and $3.48. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust."}],"balance_after":13697,"source":{"system":"sec-edgar","filing":"0001209191-22-048534","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048534/doc4.xml","form_type":"4"}},{"id":2170054,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-31T17:47:43.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":3212,"price":3.209,"value":10307.308,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average purchase price for the transaction was $3.209. The shares were purchased at a range of prices between $3.19 and $3.29. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust."}],"balance_after":6197,"source":{"system":"sec-edgar","filing":"0001209191-22-048167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048167/doc4.xml","form_type":"4"}},{"id":2170053,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-31T17:47:43.000Z","date":"2022-08-30","kind":"purchase","acquired":true,"shares":1845,"price":3.1938,"value":5892.561,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average purchase price for the transaction was $3.1938.  The shares were purchased at a range of prices between $3.16 and $3.25.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust."}],"balance_after":2985,"source":{"system":"sec-edgar","filing":"0001209191-22-048167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048167/doc4.xml","form_type":"4"}},{"id":2170052,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-31T17:47:43.000Z","date":"2022-08-30","kind":"purchase","acquired":true,"shares":975,"price":3.16,"value":3081.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average purchase price for the transaction was $3.16. The shares were purchased at a range of prices between $3.11 and $3.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":31758,"source":{"system":"sec-edgar","filing":"0001209191-22-048167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048167/doc4.xml","form_type":"4"}},{"id":2170051,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-31T17:47:43.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":1140,"price":3.24,"value":3693.6,"ownership":{"direct":false,"nature":"by Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By Michael P. Cruse and Thu Anh Thuy Cruse, Trustees of The Cruse Family Revocable Living Trust."}],"balance_after":1140,"source":{"system":"sec-edgar","filing":"0001209191-22-048167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048167/doc4.xml","form_type":"4"}},{"id":2170050,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2022-08-31T17:47:43.000Z","date":"2022-08-29","kind":"purchase","acquired":true,"shares":83,"price":3.24,"value":268.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on June 8, 2022."}],"balance_after":30783,"source":{"system":"sec-edgar","filing":"0001209191-22-048167","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122048167/doc4.xml","form_type":"4"}},{"id":2350676,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-03-04T21:51:44.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares vest in a series of 48 successive equal monthly installments measured from March 2, 2022, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":4.58,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-016541","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919122016541/doc4.xml","form_type":"4"}},{"id":2473703,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP-Corporate Operations"}}],"security":"Stock option (right to buy)","published_at":"2021-12-14T16:28:55.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares vest in a series of 48 successive equal monthly installments measured from December 10, 2021, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":6.69,"expiration_date":"2031-12-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-069436","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919121069436/doc4.xml","form_type":"4"}},{"id":2473702,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP-Corporate Operations"}}],"security":"Common Stock","published_at":"2021-12-14T16:28:55.000Z","date":"2021-12-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 8, 2021."}],"balance_after":29100,"source":{"system":"sec-edgar","filing":"0001209191-21-069436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919121069436/doc4.xml","form_type":"4"}},{"id":2589722,"issuer":{"id":6550,"kind":"organization","name":"OnKure Therapeutics, Inc.","symbol":"OKUR"},"owners":[{"id":121665,"kind":"person","name":"Cruse Michael","position":1,"cik":"0001854179","reported_name":"Cruse Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior VP-Corporate Operations"}}],"security":"Common Stock","published_at":"2021-08-26T17:51:54.000Z","date":"2021-08-25","kind":"purchase","acquired":true,"shares":2500,"price":7.4464,"value":18616.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price for the transaction was $7.4464.  The shares were purchased at a range of prices between $7.425 and $7.45.  Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001209191-21-053520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854179/000120919121053520/doc4.xml","form_type":"4"}}]}